Global Pharmacovigilance Services Production, Demand and Key Producers, 2022-2028
This report studies the global Pharmacovigilance Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmacovigilance Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmacovigilance Services that contribute to its increasing demand across many markets.
The global Pharmacovigilance Services market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Pharmacovigilance Services total market, 2017-2028, (USD Million)
Global Pharmacovigilance Services total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Pharmacovigilance Services total market, key domestic companies and share, (USD Million)
Global Pharmacovigilance Services revenue by player and market share 2017-2022, (USD Million)
Global Pharmacovigilance Services total market by Type, CAGR, 2017-2028, (USD Million)
Global Pharmacovigilance Services total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Pharmacovigilance Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PrimeVigilance, Quanticate, ProPharma, Parexel, Accenture, SOTERIUS, SGS, Medpace and PPD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmacovigilance Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Pharmacovigilance Services Market, By Region:
1. How big is the global Pharmacovigilance Services market?
2. What is the demand of the global Pharmacovigilance Services market?
3. What is the year over year growth of the global Pharmacovigilance Services market?
4. What is the total value of the global Pharmacovigilance Services market?
5. Who are the major players in the global Pharmacovigilance Services market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Pharmacovigilance Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmacovigilance Services that contribute to its increasing demand across many markets.
The global Pharmacovigilance Services market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Pharmacovigilance Services total market, 2017-2028, (USD Million)
Global Pharmacovigilance Services total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Pharmacovigilance Services total market, key domestic companies and share, (USD Million)
Global Pharmacovigilance Services revenue by player and market share 2017-2022, (USD Million)
Global Pharmacovigilance Services total market by Type, CAGR, 2017-2028, (USD Million)
Global Pharmacovigilance Services total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Pharmacovigilance Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PrimeVigilance, Quanticate, ProPharma, Parexel, Accenture, SOTERIUS, SGS, Medpace and PPD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmacovigilance Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Pharmacovigilance Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Adverse Event Case Management
- Aggregate Reporting
- Signal Intelligence
- Risk Management
- Biotechnology and Pharmaceuticals
- Contract Research Organization
- Hospital
- KPO / BPO
- Healthcare Institutions
- Others
- PrimeVigilance
- Quanticate
- ProPharma
- Parexel
- Accenture
- SOTERIUS
- SGS
- Medpace
- PPD
- QVigilance
- Freyr Solutions
- Navitas Life Sciences
- MMS Holdings
- Amarex
- Astrix Technology Group
- Cambridge Regulatory Services
- CROMSOURCE
- APCER Life Sciences
- Pharmya
- A+Science
- Midas Pharma
- George Clinical
- Syneos Health
- INPHARMATIS
- Taimei Technology
- Extedo
- WCG Clinical
1. How big is the global Pharmacovigilance Services market?
2. What is the demand of the global Pharmacovigilance Services market?
3. What is the year over year growth of the global Pharmacovigilance Services market?
4. What is the total value of the global Pharmacovigilance Services market?
5. Who are the major players in the global Pharmacovigilance Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pharmacovigilance Services Introduction
1.2 World Pharmacovigilance Services Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Pharmacovigilance Services Total Market by Region
1.3.1 World Pharmacovigilance Services Market Size by Region (2017-2028)
1.3.2 United States Pharmacovigilance Services Market Size (2017-2028)
1.3.3 China Pharmacovigilance Services Market Size (2017-2028)
1.3.4 Europe Pharmacovigilance Services Market Size (2017-2028)
1.3.5 Japan Pharmacovigilance Services Market Size (2017-2028)
1.3.6 South Korea Pharmacovigilance Services Market Size (2017-2028)
1.3.7 ASEAN Pharmacovigilance Services Market Size (2017-2028)
1.3.8 India Pharmacovigilance Services Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmacovigilance Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmacovigilance Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD PHARMACOVIGILANCE SERVICES COMPANIES COMPETITIVE ANALYSIS
2.1 World Pharmacovigilance Services Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Pharmacovigilance Services Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Pharmacovigilance Services in 2021
2.2.3 Global Concentration Ratios (CR8) for Pharmacovigilance Services in 2021
2.3 Pharmacovigilance Services Company Evaluation Quadrant
2.4 Pharmacovigilance Services Market: Overall Company Footprint Analysis
2.4.1 Pharmacovigilance Services Market: Region Footprint
2.4.2 Pharmacovigilance Services Market: Company Product Type Footprint
2.4.3 Pharmacovigilance Services Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Pharmacovigilance Services Market Comparison
3.1.1 United States VS China: Pharmacovigilance Services Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Pharmacovigilance Services Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Pharmacovigilance Services Major Players and Market Share, 2017-2022
3.2.1 Major Players of Pharmacovigilance Services in United States, Headquarters (States, Country)
3.2.2 United States Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
3.3 China Pharmacovigilance Services Major Players and Market Share, 2017-2022
3.3.1 Major Players of Pharmacovigilance Services in China, Headquarters (Province, Country)
3.3.2 China Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Pharmacovigilance Services Major Players and Market Share, 2017-2022
3.4.1 Major Players of Pharmacovigilance Services in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Pharmacovigilance Services Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Adverse Event Case Management
4.2.2 Aggregate Reporting
4.2.3 Signal Intelligence
4.2.4 Risk Management
4.3 Market Segment by Type
4.3.1 World Pharmacovigilance Services Market Size by Type (2017-2022)
4.3.2 World Pharmacovigilance Services Market Size by Type (2023-2028)
4.3.3 World Pharmacovigilance Services Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Pharmacovigilance Services Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Biotechnology and Pharmaceuticals
5.2.2 Contract Research Organization
5.2.3 Hospital
5.2.4 KPO / BPO
5.2.5 KPO / BPO
5.2.6 Others
5.3 Market Segment by Application
5.3.1 World Pharmacovigilance Services Market Size by Application (2017-2022)
5.3.2 World Pharmacovigilance Services Market Size by Application (2023-2028)
5.3.3 World Pharmacovigilance Services Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 PrimeVigilance
6.1.1 PrimeVigilance Details
6.1.2 PrimeVigilance Major Business
6.1.3 PrimeVigilance Pharmacovigilance Services Product and Services
6.1.4 PrimeVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 PrimeVigilance Recent Developments/Updates
6.1.6 PrimeVigilance Competitive Strengths & Weaknesses
6.2 Quanticate
6.2.1 Quanticate Details
6.2.2 Quanticate Major Business
6.2.3 Quanticate Pharmacovigilance Services Product and Services
6.2.4 Quanticate Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Quanticate Recent Developments/Updates
6.2.6 Quanticate Competitive Strengths & Weaknesses
6.3 ProPharma
6.3.1 ProPharma Details
6.3.2 ProPharma Major Business
6.3.3 ProPharma Pharmacovigilance Services Product and Services
6.3.4 ProPharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 ProPharma Recent Developments/Updates
6.3.6 ProPharma Competitive Strengths & Weaknesses
6.4 Parexel
6.4.1 Parexel Details
6.4.2 Parexel Major Business
6.4.3 Parexel Pharmacovigilance Services Product and Services
6.4.4 Parexel Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Parexel Recent Developments/Updates
6.4.6 Parexel Competitive Strengths & Weaknesses
6.5 Accenture
6.5.1 Accenture Details
6.5.2 Accenture Major Business
6.5.3 Accenture Pharmacovigilance Services Product and Services
6.5.4 Accenture Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Accenture Recent Developments/Updates
6.5.6 Accenture Competitive Strengths & Weaknesses
6.6 SOTERIUS
6.6.1 SOTERIUS Details
6.6.2 SOTERIUS Major Business
6.6.3 SOTERIUS Pharmacovigilance Services Product and Services
6.6.4 SOTERIUS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 SOTERIUS Recent Developments/Updates
6.6.6 SOTERIUS Competitive Strengths & Weaknesses
6.7 SGS
6.7.1 SGS Details
6.7.2 SGS Major Business
6.7.3 SGS Pharmacovigilance Services Product and Services
6.7.4 SGS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 SGS Recent Developments/Updates
6.7.6 SGS Competitive Strengths & Weaknesses
6.8 Medpace
6.8.1 Medpace Details
6.8.2 Medpace Major Business
6.8.3 Medpace Pharmacovigilance Services Product and Services
6.8.4 Medpace Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Medpace Recent Developments/Updates
6.8.6 Medpace Competitive Strengths & Weaknesses
6.9 PPD
6.9.1 PPD Details
6.9.2 PPD Major Business
6.9.3 PPD Pharmacovigilance Services Product and Services
6.9.4 PPD Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 PPD Recent Developments/Updates
6.9.6 PPD Competitive Strengths & Weaknesses
6.10 QVigilance
6.10.1 QVigilance Details
6.10.2 QVigilance Major Business
6.10.3 QVigilance Pharmacovigilance Services Product and Services
6.10.4 QVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 QVigilance Recent Developments/Updates
6.10.6 QVigilance Competitive Strengths & Weaknesses
6.11 Freyr Solutions
6.11.1 Freyr Solutions Details
6.11.2 Freyr Solutions Major Business
6.11.3 Freyr Solutions Pharmacovigilance Services Product and Services
6.11.4 Freyr Solutions Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Freyr Solutions Recent Developments/Updates
6.11.6 Freyr Solutions Competitive Strengths & Weaknesses
6.12 Navitas Life Sciences
6.12.1 Navitas Life Sciences Details
6.12.2 Navitas Life Sciences Major Business
6.12.3 Navitas Life Sciences Pharmacovigilance Services Product and Services
6.12.4 Navitas Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Navitas Life Sciences Recent Developments/Updates
6.12.6 Navitas Life Sciences Competitive Strengths & Weaknesses
6.13 MMS Holdings
6.13.1 MMS Holdings Details
6.13.2 MMS Holdings Major Business
6.13.3 MMS Holdings Pharmacovigilance Services Product and Services
6.13.4 MMS Holdings Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 MMS Holdings Recent Developments/Updates
6.13.6 MMS Holdings Competitive Strengths & Weaknesses
6.14 Amarex
6.14.1 Amarex Details
6.14.2 Amarex Major Business
6.14.3 Amarex Pharmacovigilance Services Product and Services
6.14.4 Amarex Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Amarex Recent Developments/Updates
6.14.6 Amarex Competitive Strengths & Weaknesses
6.15 Astrix Technology Group
6.15.1 Astrix Technology Group Details
6.15.2 Astrix Technology Group Major Business
6.15.3 Astrix Technology Group Pharmacovigilance Services Product and Services
6.15.4 Astrix Technology Group Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Astrix Technology Group Recent Developments/Updates
6.15.6 Astrix Technology Group Competitive Strengths & Weaknesses
6.16 Cambridge Regulatory Services
6.16.1 Cambridge Regulatory Services Details
6.16.2 Cambridge Regulatory Services Major Business
6.16.3 Cambridge Regulatory Services Pharmacovigilance Services Product and Services
6.16.4 Cambridge Regulatory Services Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Cambridge Regulatory Services Recent Developments/Updates
6.16.6 Cambridge Regulatory Services Competitive Strengths & Weaknesses
6.17 CROMSOURCE
6.17.1 CROMSOURCE Details
6.17.2 CROMSOURCE Major Business
6.17.3 CROMSOURCE Pharmacovigilance Services Product and Services
6.17.4 CROMSOURCE Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 CROMSOURCE Recent Developments/Updates
6.17.6 CROMSOURCE Competitive Strengths & Weaknesses
6.18 APCER Life Sciences
6.18.1 APCER Life Sciences Details
6.18.2 APCER Life Sciences Major Business
6.18.3 APCER Life Sciences Pharmacovigilance Services Product and Services
6.18.4 APCER Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 APCER Life Sciences Recent Developments/Updates
6.18.6 APCER Life Sciences Competitive Strengths & Weaknesses
6.19 Pharmya
6.19.1 Pharmya Details
6.19.2 Pharmya Major Business
6.19.3 Pharmya Pharmacovigilance Services Product and Services
6.19.4 Pharmya Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Pharmya Recent Developments/Updates
6.19.6 Pharmya Competitive Strengths & Weaknesses
6.20 A+Science
6.20.1 A+Science Details
6.20.2 A+Science Major Business
6.20.3 A+Science Pharmacovigilance Services Product and Services
6.20.4 A+Science Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 A+Science Recent Developments/Updates
6.20.6 A+Science Competitive Strengths & Weaknesses
6.21 Midas Pharma
6.21.1 Midas Pharma Details
6.21.2 Midas Pharma Major Business
6.21.3 Midas Pharma Pharmacovigilance Services Product and Services
6.21.4 Midas Pharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Midas Pharma Recent Developments/Updates
6.21.6 Midas Pharma Competitive Strengths & Weaknesses
6.22 George Clinical
6.22.1 George Clinical Details
6.22.2 George Clinical Major Business
6.22.3 George Clinical Pharmacovigilance Services Product and Services
6.22.4 George Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 George Clinical Recent Developments/Updates
6.22.6 George Clinical Competitive Strengths & Weaknesses
6.23 Syneos Health
6.23.1 Syneos Health Details
6.23.2 Syneos Health Major Business
6.23.3 Syneos Health Pharmacovigilance Services Product and Services
6.23.4 Syneos Health Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 Syneos Health Recent Developments/Updates
6.23.6 Syneos Health Competitive Strengths & Weaknesses
6.24 INPHARMATIS
6.24.1 INPHARMATIS Details
6.24.2 INPHARMATIS Major Business
6.24.3 INPHARMATIS Pharmacovigilance Services Product and Services
6.24.4 INPHARMATIS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.24.5 INPHARMATIS Recent Developments/Updates
6.24.6 INPHARMATIS Competitive Strengths & Weaknesses
6.25 Taimei Technology
6.25.1 Taimei Technology Details
6.25.2 Taimei Technology Major Business
6.25.3 Taimei Technology Pharmacovigilance Services Product and Services
6.25.4 Taimei Technology Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.25.5 Taimei Technology Recent Developments/Updates
6.25.6 Taimei Technology Competitive Strengths & Weaknesses
6.26 Extedo
6.26.1 Extedo Details
6.26.2 Extedo Major Business
6.26.3 Extedo Pharmacovigilance Services Product and Services
6.26.4 Extedo Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.26.5 Extedo Recent Developments/Updates
6.26.6 Extedo Competitive Strengths & Weaknesses
6.27 WCG Clinical
6.27.1 WCG Clinical Details
6.27.2 WCG Clinical Major Business
6.27.3 WCG Clinical Pharmacovigilance Services Product and Services
6.27.4 WCG Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.27.5 WCG Clinical Recent Developments/Updates
6.27.6 WCG Clinical Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Pharmacovigilance Services and Key Manufacturers
7.2 Pharmacovigilance Services Manufacturing Costs
7.3 Pharmacovigilance Services Production Process
7.4 Pharmacovigilance Services Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Pharmacovigilance Services Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Pharmacovigilance Services Typical Distributors
8.3 Pharmacovigilance Services Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pharmacovigilance Services Introduction
1.2 World Pharmacovigilance Services Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Pharmacovigilance Services Total Market by Region
1.3.1 World Pharmacovigilance Services Market Size by Region (2017-2028)
1.3.2 United States Pharmacovigilance Services Market Size (2017-2028)
1.3.3 China Pharmacovigilance Services Market Size (2017-2028)
1.3.4 Europe Pharmacovigilance Services Market Size (2017-2028)
1.3.5 Japan Pharmacovigilance Services Market Size (2017-2028)
1.3.6 South Korea Pharmacovigilance Services Market Size (2017-2028)
1.3.7 ASEAN Pharmacovigilance Services Market Size (2017-2028)
1.3.8 India Pharmacovigilance Services Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmacovigilance Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmacovigilance Services Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD PHARMACOVIGILANCE SERVICES COMPANIES COMPETITIVE ANALYSIS
2.1 World Pharmacovigilance Services Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Pharmacovigilance Services Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Pharmacovigilance Services in 2021
2.2.3 Global Concentration Ratios (CR8) for Pharmacovigilance Services in 2021
2.3 Pharmacovigilance Services Company Evaluation Quadrant
2.4 Pharmacovigilance Services Market: Overall Company Footprint Analysis
2.4.1 Pharmacovigilance Services Market: Region Footprint
2.4.2 Pharmacovigilance Services Market: Company Product Type Footprint
2.4.3 Pharmacovigilance Services Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Pharmacovigilance Services Market Comparison
3.1.1 United States VS China: Pharmacovigilance Services Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Pharmacovigilance Services Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Pharmacovigilance Services Major Players and Market Share, 2017-2022
3.2.1 Major Players of Pharmacovigilance Services in United States, Headquarters (States, Country)
3.2.2 United States Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
3.3 China Pharmacovigilance Services Major Players and Market Share, 2017-2022
3.3.1 Major Players of Pharmacovigilance Services in China, Headquarters (Province, Country)
3.3.2 China Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Pharmacovigilance Services Major Players and Market Share, 2017-2022
3.4.1 Major Players of Pharmacovigilance Services in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Pharmacovigilance Services Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Pharmacovigilance Services Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Adverse Event Case Management
4.2.2 Aggregate Reporting
4.2.3 Signal Intelligence
4.2.4 Risk Management
4.3 Market Segment by Type
4.3.1 World Pharmacovigilance Services Market Size by Type (2017-2022)
4.3.2 World Pharmacovigilance Services Market Size by Type (2023-2028)
4.3.3 World Pharmacovigilance Services Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Pharmacovigilance Services Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Biotechnology and Pharmaceuticals
5.2.2 Contract Research Organization
5.2.3 Hospital
5.2.4 KPO / BPO
5.2.5 KPO / BPO
5.2.6 Others
5.3 Market Segment by Application
5.3.1 World Pharmacovigilance Services Market Size by Application (2017-2022)
5.3.2 World Pharmacovigilance Services Market Size by Application (2023-2028)
5.3.3 World Pharmacovigilance Services Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 PrimeVigilance
6.1.1 PrimeVigilance Details
6.1.2 PrimeVigilance Major Business
6.1.3 PrimeVigilance Pharmacovigilance Services Product and Services
6.1.4 PrimeVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 PrimeVigilance Recent Developments/Updates
6.1.6 PrimeVigilance Competitive Strengths & Weaknesses
6.2 Quanticate
6.2.1 Quanticate Details
6.2.2 Quanticate Major Business
6.2.3 Quanticate Pharmacovigilance Services Product and Services
6.2.4 Quanticate Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Quanticate Recent Developments/Updates
6.2.6 Quanticate Competitive Strengths & Weaknesses
6.3 ProPharma
6.3.1 ProPharma Details
6.3.2 ProPharma Major Business
6.3.3 ProPharma Pharmacovigilance Services Product and Services
6.3.4 ProPharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 ProPharma Recent Developments/Updates
6.3.6 ProPharma Competitive Strengths & Weaknesses
6.4 Parexel
6.4.1 Parexel Details
6.4.2 Parexel Major Business
6.4.3 Parexel Pharmacovigilance Services Product and Services
6.4.4 Parexel Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Parexel Recent Developments/Updates
6.4.6 Parexel Competitive Strengths & Weaknesses
6.5 Accenture
6.5.1 Accenture Details
6.5.2 Accenture Major Business
6.5.3 Accenture Pharmacovigilance Services Product and Services
6.5.4 Accenture Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Accenture Recent Developments/Updates
6.5.6 Accenture Competitive Strengths & Weaknesses
6.6 SOTERIUS
6.6.1 SOTERIUS Details
6.6.2 SOTERIUS Major Business
6.6.3 SOTERIUS Pharmacovigilance Services Product and Services
6.6.4 SOTERIUS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 SOTERIUS Recent Developments/Updates
6.6.6 SOTERIUS Competitive Strengths & Weaknesses
6.7 SGS
6.7.1 SGS Details
6.7.2 SGS Major Business
6.7.3 SGS Pharmacovigilance Services Product and Services
6.7.4 SGS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 SGS Recent Developments/Updates
6.7.6 SGS Competitive Strengths & Weaknesses
6.8 Medpace
6.8.1 Medpace Details
6.8.2 Medpace Major Business
6.8.3 Medpace Pharmacovigilance Services Product and Services
6.8.4 Medpace Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Medpace Recent Developments/Updates
6.8.6 Medpace Competitive Strengths & Weaknesses
6.9 PPD
6.9.1 PPD Details
6.9.2 PPD Major Business
6.9.3 PPD Pharmacovigilance Services Product and Services
6.9.4 PPD Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 PPD Recent Developments/Updates
6.9.6 PPD Competitive Strengths & Weaknesses
6.10 QVigilance
6.10.1 QVigilance Details
6.10.2 QVigilance Major Business
6.10.3 QVigilance Pharmacovigilance Services Product and Services
6.10.4 QVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 QVigilance Recent Developments/Updates
6.10.6 QVigilance Competitive Strengths & Weaknesses
6.11 Freyr Solutions
6.11.1 Freyr Solutions Details
6.11.2 Freyr Solutions Major Business
6.11.3 Freyr Solutions Pharmacovigilance Services Product and Services
6.11.4 Freyr Solutions Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Freyr Solutions Recent Developments/Updates
6.11.6 Freyr Solutions Competitive Strengths & Weaknesses
6.12 Navitas Life Sciences
6.12.1 Navitas Life Sciences Details
6.12.2 Navitas Life Sciences Major Business
6.12.3 Navitas Life Sciences Pharmacovigilance Services Product and Services
6.12.4 Navitas Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Navitas Life Sciences Recent Developments/Updates
6.12.6 Navitas Life Sciences Competitive Strengths & Weaknesses
6.13 MMS Holdings
6.13.1 MMS Holdings Details
6.13.2 MMS Holdings Major Business
6.13.3 MMS Holdings Pharmacovigilance Services Product and Services
6.13.4 MMS Holdings Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 MMS Holdings Recent Developments/Updates
6.13.6 MMS Holdings Competitive Strengths & Weaknesses
6.14 Amarex
6.14.1 Amarex Details
6.14.2 Amarex Major Business
6.14.3 Amarex Pharmacovigilance Services Product and Services
6.14.4 Amarex Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Amarex Recent Developments/Updates
6.14.6 Amarex Competitive Strengths & Weaknesses
6.15 Astrix Technology Group
6.15.1 Astrix Technology Group Details
6.15.2 Astrix Technology Group Major Business
6.15.3 Astrix Technology Group Pharmacovigilance Services Product and Services
6.15.4 Astrix Technology Group Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Astrix Technology Group Recent Developments/Updates
6.15.6 Astrix Technology Group Competitive Strengths & Weaknesses
6.16 Cambridge Regulatory Services
6.16.1 Cambridge Regulatory Services Details
6.16.2 Cambridge Regulatory Services Major Business
6.16.3 Cambridge Regulatory Services Pharmacovigilance Services Product and Services
6.16.4 Cambridge Regulatory Services Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Cambridge Regulatory Services Recent Developments/Updates
6.16.6 Cambridge Regulatory Services Competitive Strengths & Weaknesses
6.17 CROMSOURCE
6.17.1 CROMSOURCE Details
6.17.2 CROMSOURCE Major Business
6.17.3 CROMSOURCE Pharmacovigilance Services Product and Services
6.17.4 CROMSOURCE Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 CROMSOURCE Recent Developments/Updates
6.17.6 CROMSOURCE Competitive Strengths & Weaknesses
6.18 APCER Life Sciences
6.18.1 APCER Life Sciences Details
6.18.2 APCER Life Sciences Major Business
6.18.3 APCER Life Sciences Pharmacovigilance Services Product and Services
6.18.4 APCER Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 APCER Life Sciences Recent Developments/Updates
6.18.6 APCER Life Sciences Competitive Strengths & Weaknesses
6.19 Pharmya
6.19.1 Pharmya Details
6.19.2 Pharmya Major Business
6.19.3 Pharmya Pharmacovigilance Services Product and Services
6.19.4 Pharmya Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Pharmya Recent Developments/Updates
6.19.6 Pharmya Competitive Strengths & Weaknesses
6.20 A+Science
6.20.1 A+Science Details
6.20.2 A+Science Major Business
6.20.3 A+Science Pharmacovigilance Services Product and Services
6.20.4 A+Science Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 A+Science Recent Developments/Updates
6.20.6 A+Science Competitive Strengths & Weaknesses
6.21 Midas Pharma
6.21.1 Midas Pharma Details
6.21.2 Midas Pharma Major Business
6.21.3 Midas Pharma Pharmacovigilance Services Product and Services
6.21.4 Midas Pharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Midas Pharma Recent Developments/Updates
6.21.6 Midas Pharma Competitive Strengths & Weaknesses
6.22 George Clinical
6.22.1 George Clinical Details
6.22.2 George Clinical Major Business
6.22.3 George Clinical Pharmacovigilance Services Product and Services
6.22.4 George Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 George Clinical Recent Developments/Updates
6.22.6 George Clinical Competitive Strengths & Weaknesses
6.23 Syneos Health
6.23.1 Syneos Health Details
6.23.2 Syneos Health Major Business
6.23.3 Syneos Health Pharmacovigilance Services Product and Services
6.23.4 Syneos Health Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 Syneos Health Recent Developments/Updates
6.23.6 Syneos Health Competitive Strengths & Weaknesses
6.24 INPHARMATIS
6.24.1 INPHARMATIS Details
6.24.2 INPHARMATIS Major Business
6.24.3 INPHARMATIS Pharmacovigilance Services Product and Services
6.24.4 INPHARMATIS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.24.5 INPHARMATIS Recent Developments/Updates
6.24.6 INPHARMATIS Competitive Strengths & Weaknesses
6.25 Taimei Technology
6.25.1 Taimei Technology Details
6.25.2 Taimei Technology Major Business
6.25.3 Taimei Technology Pharmacovigilance Services Product and Services
6.25.4 Taimei Technology Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.25.5 Taimei Technology Recent Developments/Updates
6.25.6 Taimei Technology Competitive Strengths & Weaknesses
6.26 Extedo
6.26.1 Extedo Details
6.26.2 Extedo Major Business
6.26.3 Extedo Pharmacovigilance Services Product and Services
6.26.4 Extedo Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.26.5 Extedo Recent Developments/Updates
6.26.6 Extedo Competitive Strengths & Weaknesses
6.27 WCG Clinical
6.27.1 WCG Clinical Details
6.27.2 WCG Clinical Major Business
6.27.3 WCG Clinical Pharmacovigilance Services Product and Services
6.27.4 WCG Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022)
6.27.5 WCG Clinical Recent Developments/Updates
6.27.6 WCG Clinical Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Pharmacovigilance Services and Key Manufacturers
7.2 Pharmacovigilance Services Manufacturing Costs
7.3 Pharmacovigilance Services Production Process
7.4 Pharmacovigilance Services Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Pharmacovigilance Services Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Pharmacovigilance Services Typical Distributors
8.3 Pharmacovigilance Services Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pharmacovigilance Services Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Pharmacovigilance Services Market Size by Region (2017-2022) & (USD Million)
Table 3. World Pharmacovigilance Services Market Size by Region (2023-2028) & (USD Million)
Table 4. World Pharmacovigilance Services Market Size Market Share by Region (2017-2022)
Table 5. World Pharmacovigilance Services Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Pharmacovigilance Services Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Pharmacovigilance Services Players in 2021
Table 9. World Pharmacovigilance Services Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Pharmacovigilance Services Company Evaluation Quadrant
Table 11. Head Office of Key Pharmacovigilance Services Player
Table 12. Pharmacovigilance Services Market: Company Product Type Footprint
Table 13. Pharmacovigilance Services Market: Company Product Application Footprint
Table 14. Pharmacovigilance Services Mergers & Acquisitions Activity
Table 15. United States VS China Pharmacovigilance Services Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Pharmacovigilance Services in United States, Headquarters (States, Country)
Table 17. United States Pharmacovigilance Services Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Pharmacovigilance Services Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Pharmacovigilance Services in China, Company Headquarters (Province, Country)
Table 20. China Pharmacovigilance Services Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Pharmacovigilance Services Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Pharmacovigilance Services in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Pharmacovigilance Services Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Pharmacovigilance Services Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Pharmacovigilance Services Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Pharmacovigilance Services Revenue by Type (2017-2022) & (USD Million)
Table 27. World Pharmacovigilance Services Revenue by Type (2023-2028) & (USD Million)
Table 28. World Pharmacovigilance Services Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Pharmacovigilance Services Revenue by Application (2017-2022) & (USD Million)
Table 30. World Pharmacovigilance Services Revenue by Application (2023-2028) & (USD Million)
Table 31. PrimeVigilance Basic Information, Manufacturing Base and Competitors
Table 32. PrimeVigilance Major Business
Table 33. PrimeVigilance Pharmacovigilance Services Product and Services
Table 34. PrimeVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. PrimeVigilance Recent Developments/Updates
Table 36. PrimeVigilance Competitive Strengths & Weaknesses
Table 37. Quanticate Basic Information, Manufacturing Base and Competitors
Table 38. Quanticate Major Business
Table 39. Quanticate Pharmacovigilance Services Product and Services
Table 40. Quanticate Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Quanticate Recent Developments/Updates
Table 42. Quanticate Competitive Strengths & Weaknesses
Table 43. ProPharma Basic Information, Manufacturing Base and Competitors
Table 44. ProPharma Major Business
Table 45. ProPharma Pharmacovigilance Services Product and Services
Table 46. ProPharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. ProPharma Recent Developments/Updates
Table 48. ProPharma Competitive Strengths & Weaknesses
Table 49. Parexel Basic Information, Manufacturing Base and Competitors
Table 50. Parexel Major Business
Table 51. Parexel Pharmacovigilance Services Product and Services
Table 52. Parexel Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Parexel Recent Developments/Updates
Table 54. Parexel Competitive Strengths & Weaknesses
Table 55. Accenture Basic Information, Manufacturing Base and Competitors
Table 56. Accenture Major Business
Table 57. Accenture Pharmacovigilance Services Product and Services
Table 58. Accenture Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Accenture Recent Developments/Updates
Table 60. Accenture Competitive Strengths & Weaknesses
Table 61. SOTERIUS Basic Information, Manufacturing Base and Competitors
Table 62. SOTERIUS Major Business
Table 63. SOTERIUS Pharmacovigilance Services Product and Services
Table 64. SOTERIUS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. SOTERIUS Recent Developments/Updates
Table 66. SOTERIUS Competitive Strengths & Weaknesses
Table 67. SGS Basic Information, Manufacturing Base and Competitors
Table 68. SGS Major Business
Table 69. SGS Pharmacovigilance Services Product and Services
Table 70. SGS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. SGS Recent Developments/Updates
Table 72. SGS Competitive Strengths & Weaknesses
Table 73. Medpace Basic Information, Manufacturing Base and Competitors
Table 74. Medpace Major Business
Table 75. Medpace Pharmacovigilance Services Product and Services
Table 76. Medpace Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Medpace Recent Developments/Updates
Table 78. Medpace Competitive Strengths & Weaknesses
Table 79. PPD Basic Information, Manufacturing Base and Competitors
Table 80. PPD Major Business
Table 81. PPD Pharmacovigilance Services Product and Services
Table 82. PPD Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. PPD Recent Developments/Updates
Table 84. PPD Competitive Strengths & Weaknesses
Table 85. QVigilance Basic Information, Manufacturing Base and Competitors
Table 86. QVigilance Major Business
Table 87. QVigilance Pharmacovigilance Services Product and Services
Table 88. QVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. QVigilance Recent Developments/Updates
Table 90. QVigilance Competitive Strengths & Weaknesses
Table 91. Freyr Solutions Basic Information, Manufacturing Base and Competitors
Table 92. Freyr Solutions Major Business
Table 93. Freyr Solutions Pharmacovigilance Services Product and Services
Table 94. Freyr Solutions Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Freyr Solutions Recent Developments/Updates
Table 96. Freyr Solutions Competitive Strengths & Weaknesses
Table 97. Navitas Life Sciences Basic Information, Manufacturing Base and Competitors
Table 98. Navitas Life Sciences Major Business
Table 99. Navitas Life Sciences Pharmacovigilance Services Product and Services
Table 100. Navitas Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Navitas Life Sciences Recent Developments/Updates
Table 102. Navitas Life Sciences Competitive Strengths & Weaknesses
Table 103. MMS Holdings Basic Information, Manufacturing Base and Competitors
Table 104. MMS Holdings Major Business
Table 105. MMS Holdings Pharmacovigilance Services Product and Services
Table 106. MMS Holdings Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. MMS Holdings Recent Developments/Updates
Table 108. MMS Holdings Competitive Strengths & Weaknesses
Table 109. Amarex Basic Information, Manufacturing Base and Competitors
Table 110. Amarex Major Business
Table 111. Amarex Pharmacovigilance Services Product and Services
Table 112. Amarex Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Amarex Recent Developments/Updates
Table 114. Amarex Competitive Strengths & Weaknesses
Table 115. Astrix Technology Group Basic Information, Manufacturing Base and Competitors
Table 116. Astrix Technology Group Major Business
Table 117. Astrix Technology Group Pharmacovigilance Services Product and Services
Table 118. Astrix Technology Group Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Astrix Technology Group Recent Developments/Updates
Table 120. Astrix Technology Group Competitive Strengths & Weaknesses
Table 121. Cambridge Regulatory Services Basic Information, Manufacturing Base and Competitors
Table 122. Cambridge Regulatory Services Major Business
Table 123. Cambridge Regulatory Services Pharmacovigilance Services Product and Services
Table 124. Cambridge Regulatory Services Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Cambridge Regulatory Services Recent Developments/Updates
Table 126. Cambridge Regulatory Services Competitive Strengths & Weaknesses
Table 127. CROMSOURCE Basic Information, Manufacturing Base and Competitors
Table 128. CROMSOURCE Major Business
Table 129. CROMSOURCE Pharmacovigilance Services Product and Services
Table 130. CROMSOURCE Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. CROMSOURCE Recent Developments/Updates
Table 132. CROMSOURCE Competitive Strengths & Weaknesses
Table 133. APCER Life Sciences Basic Information, Manufacturing Base and Competitors
Table 134. APCER Life Sciences Major Business
Table 135. APCER Life Sciences Pharmacovigilance Services Product and Services
Table 136. APCER Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. APCER Life Sciences Recent Developments/Updates
Table 138. APCER Life Sciences Competitive Strengths & Weaknesses
Table 139. Pharmya Basic Information, Manufacturing Base and Competitors
Table 140. Pharmya Major Business
Table 141. Pharmya Pharmacovigilance Services Product and Services
Table 142. Pharmya Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Pharmya Recent Developments/Updates
Table 144. Pharmya Competitive Strengths & Weaknesses
Table 145. A+Science Basic Information, Manufacturing Base and Competitors
Table 146. A+Science Major Business
Table 147. A+Science Pharmacovigilance Services Product and Services
Table 148. A+Science Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. A+Science Recent Developments/Updates
Table 150. A+Science Competitive Strengths & Weaknesses
Table 151. Midas Pharma Basic Information, Manufacturing Base and Competitors
Table 152. Midas Pharma Major Business
Table 153. Midas Pharma Pharmacovigilance Services Product and Services
Table 154. Midas Pharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Midas Pharma Recent Developments/Updates
Table 156. Midas Pharma Competitive Strengths & Weaknesses
Table 157. George Clinical Basic Information, Manufacturing Base and Competitors
Table 158. George Clinical Major Business
Table 159. George Clinical Pharmacovigilance Services Product and Services
Table 160. George Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. George Clinical Recent Developments/Updates
Table 162. George Clinical Competitive Strengths & Weaknesses
Table 163. Syneos Health Basic Information, Manufacturing Base and Competitors
Table 164. Syneos Health Major Business
Table 165. Syneos Health Pharmacovigilance Services Product and Services
Table 166. Syneos Health Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 167. Syneos Health Recent Developments/Updates
Table 168. Syneos Health Competitive Strengths & Weaknesses
Table 169. INPHARMATIS Basic Information, Manufacturing Base and Competitors
Table 170. INPHARMATIS Major Business
Table 171. INPHARMATIS Pharmacovigilance Services Product and Services
Table 172. INPHARMATIS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 173. INPHARMATIS Recent Developments/Updates
Table 174. INPHARMATIS Competitive Strengths & Weaknesses
Table 175. Taimei Technology Basic Information, Manufacturing Base and Competitors
Table 176. Taimei Technology Major Business
Table 177. Taimei Technology Pharmacovigilance Services Product and Services
Table 178. Taimei Technology Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 179. Taimei Technology Recent Developments/Updates
Table 180. Taimei Technology Competitive Strengths & Weaknesses
Table 181. Extedo Basic Information, Manufacturing Base and Competitors
Table 182. Extedo Major Business
Table 183. Extedo Pharmacovigilance Services Product and Services
Table 184. Extedo Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 185. Extedo Recent Developments/Updates
Table 186. WCG Clinical Basic Information, Manufacturing Base and Competitors
Table 187. WCG Clinical Major Business
Table 188. WCG Clinical Pharmacovigilance Services Product and Services
Table 189. WCG Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 190. Pharmacovigilance Services Raw Material
Table 191. Key Manufacturers of Pharmacovigilance Services Raw Materials
Table 192. Pharmacovigilance Services Typical Distributors
Table 193. Pharmacovigilance Services Typical Customers
List of Figure
Figure 1. Pharmacovigilance Services Picture
Figure 2. World Pharmacovigilance Services Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Pharmacovigilance Services Total Market Size (2017-2028) & (USD Million)
Figure 4. World Pharmacovigilance Services Market Size Market Share by Region (2017-2028)
Figure 5. United States Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 6. China Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 7. Europe Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 8. Japan Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 11. India Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 12. Pharmacovigilance Services Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Pharmacovigilance Services by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Pharmacovigilance Services Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Pharmacovigilance Services Markets in 2021
Figure 17. United States VS China: Pharmacovigilance Services Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Pharmacovigilance Services Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Pharmacovigilance Services Market Size Market Share by Type in 2021
Figure 20. Adverse Event Case Management
Figure 21. Aggregate Reporting
Figure 22. Signal Intelligence
Figure 23. Risk Management
Figure 24. World Pharmacovigilance Services Market Size Market Share by Type (2017-2028)
Figure 25. World Pharmacovigilance Services Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Pharmacovigilance Services Market Size Market Share by Application in 2021
Figure 27. Biotechnology and Pharmaceuticals
Figure 28. Contract Research Organization
Figure 29. Hospital
Figure 30. KPO / BPO
Figure 31. Healthcare Institutions
Figure 32. Others
Figure 33. World Pharmacovigilance Services Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Pharmacovigilance Services in 2021
Figure 35. Manufacturing Process Analysis of Pharmacovigilance Services
Figure 36. Pharmacovigilance Services Industrial Chain
Figure 37. Distribution Channel Breakdown for Pharmacovigilance Services Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Pharmacovigilance Services Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Pharmacovigilance Services Market Size by Region (2017-2022) & (USD Million)
Table 3. World Pharmacovigilance Services Market Size by Region (2023-2028) & (USD Million)
Table 4. World Pharmacovigilance Services Market Size Market Share by Region (2017-2022)
Table 5. World Pharmacovigilance Services Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Pharmacovigilance Services Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Pharmacovigilance Services Players in 2021
Table 9. World Pharmacovigilance Services Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Pharmacovigilance Services Company Evaluation Quadrant
Table 11. Head Office of Key Pharmacovigilance Services Player
Table 12. Pharmacovigilance Services Market: Company Product Type Footprint
Table 13. Pharmacovigilance Services Market: Company Product Application Footprint
Table 14. Pharmacovigilance Services Mergers & Acquisitions Activity
Table 15. United States VS China Pharmacovigilance Services Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Pharmacovigilance Services in United States, Headquarters (States, Country)
Table 17. United States Pharmacovigilance Services Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Pharmacovigilance Services Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Pharmacovigilance Services in China, Company Headquarters (Province, Country)
Table 20. China Pharmacovigilance Services Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Pharmacovigilance Services Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Pharmacovigilance Services in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Pharmacovigilance Services Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Pharmacovigilance Services Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Pharmacovigilance Services Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Pharmacovigilance Services Revenue by Type (2017-2022) & (USD Million)
Table 27. World Pharmacovigilance Services Revenue by Type (2023-2028) & (USD Million)
Table 28. World Pharmacovigilance Services Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Pharmacovigilance Services Revenue by Application (2017-2022) & (USD Million)
Table 30. World Pharmacovigilance Services Revenue by Application (2023-2028) & (USD Million)
Table 31. PrimeVigilance Basic Information, Manufacturing Base and Competitors
Table 32. PrimeVigilance Major Business
Table 33. PrimeVigilance Pharmacovigilance Services Product and Services
Table 34. PrimeVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. PrimeVigilance Recent Developments/Updates
Table 36. PrimeVigilance Competitive Strengths & Weaknesses
Table 37. Quanticate Basic Information, Manufacturing Base and Competitors
Table 38. Quanticate Major Business
Table 39. Quanticate Pharmacovigilance Services Product and Services
Table 40. Quanticate Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Quanticate Recent Developments/Updates
Table 42. Quanticate Competitive Strengths & Weaknesses
Table 43. ProPharma Basic Information, Manufacturing Base and Competitors
Table 44. ProPharma Major Business
Table 45. ProPharma Pharmacovigilance Services Product and Services
Table 46. ProPharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. ProPharma Recent Developments/Updates
Table 48. ProPharma Competitive Strengths & Weaknesses
Table 49. Parexel Basic Information, Manufacturing Base and Competitors
Table 50. Parexel Major Business
Table 51. Parexel Pharmacovigilance Services Product and Services
Table 52. Parexel Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Parexel Recent Developments/Updates
Table 54. Parexel Competitive Strengths & Weaknesses
Table 55. Accenture Basic Information, Manufacturing Base and Competitors
Table 56. Accenture Major Business
Table 57. Accenture Pharmacovigilance Services Product and Services
Table 58. Accenture Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Accenture Recent Developments/Updates
Table 60. Accenture Competitive Strengths & Weaknesses
Table 61. SOTERIUS Basic Information, Manufacturing Base and Competitors
Table 62. SOTERIUS Major Business
Table 63. SOTERIUS Pharmacovigilance Services Product and Services
Table 64. SOTERIUS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. SOTERIUS Recent Developments/Updates
Table 66. SOTERIUS Competitive Strengths & Weaknesses
Table 67. SGS Basic Information, Manufacturing Base and Competitors
Table 68. SGS Major Business
Table 69. SGS Pharmacovigilance Services Product and Services
Table 70. SGS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. SGS Recent Developments/Updates
Table 72. SGS Competitive Strengths & Weaknesses
Table 73. Medpace Basic Information, Manufacturing Base and Competitors
Table 74. Medpace Major Business
Table 75. Medpace Pharmacovigilance Services Product and Services
Table 76. Medpace Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Medpace Recent Developments/Updates
Table 78. Medpace Competitive Strengths & Weaknesses
Table 79. PPD Basic Information, Manufacturing Base and Competitors
Table 80. PPD Major Business
Table 81. PPD Pharmacovigilance Services Product and Services
Table 82. PPD Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. PPD Recent Developments/Updates
Table 84. PPD Competitive Strengths & Weaknesses
Table 85. QVigilance Basic Information, Manufacturing Base and Competitors
Table 86. QVigilance Major Business
Table 87. QVigilance Pharmacovigilance Services Product and Services
Table 88. QVigilance Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. QVigilance Recent Developments/Updates
Table 90. QVigilance Competitive Strengths & Weaknesses
Table 91. Freyr Solutions Basic Information, Manufacturing Base and Competitors
Table 92. Freyr Solutions Major Business
Table 93. Freyr Solutions Pharmacovigilance Services Product and Services
Table 94. Freyr Solutions Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Freyr Solutions Recent Developments/Updates
Table 96. Freyr Solutions Competitive Strengths & Weaknesses
Table 97. Navitas Life Sciences Basic Information, Manufacturing Base and Competitors
Table 98. Navitas Life Sciences Major Business
Table 99. Navitas Life Sciences Pharmacovigilance Services Product and Services
Table 100. Navitas Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Navitas Life Sciences Recent Developments/Updates
Table 102. Navitas Life Sciences Competitive Strengths & Weaknesses
Table 103. MMS Holdings Basic Information, Manufacturing Base and Competitors
Table 104. MMS Holdings Major Business
Table 105. MMS Holdings Pharmacovigilance Services Product and Services
Table 106. MMS Holdings Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. MMS Holdings Recent Developments/Updates
Table 108. MMS Holdings Competitive Strengths & Weaknesses
Table 109. Amarex Basic Information, Manufacturing Base and Competitors
Table 110. Amarex Major Business
Table 111. Amarex Pharmacovigilance Services Product and Services
Table 112. Amarex Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Amarex Recent Developments/Updates
Table 114. Amarex Competitive Strengths & Weaknesses
Table 115. Astrix Technology Group Basic Information, Manufacturing Base and Competitors
Table 116. Astrix Technology Group Major Business
Table 117. Astrix Technology Group Pharmacovigilance Services Product and Services
Table 118. Astrix Technology Group Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Astrix Technology Group Recent Developments/Updates
Table 120. Astrix Technology Group Competitive Strengths & Weaknesses
Table 121. Cambridge Regulatory Services Basic Information, Manufacturing Base and Competitors
Table 122. Cambridge Regulatory Services Major Business
Table 123. Cambridge Regulatory Services Pharmacovigilance Services Product and Services
Table 124. Cambridge Regulatory Services Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Cambridge Regulatory Services Recent Developments/Updates
Table 126. Cambridge Regulatory Services Competitive Strengths & Weaknesses
Table 127. CROMSOURCE Basic Information, Manufacturing Base and Competitors
Table 128. CROMSOURCE Major Business
Table 129. CROMSOURCE Pharmacovigilance Services Product and Services
Table 130. CROMSOURCE Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. CROMSOURCE Recent Developments/Updates
Table 132. CROMSOURCE Competitive Strengths & Weaknesses
Table 133. APCER Life Sciences Basic Information, Manufacturing Base and Competitors
Table 134. APCER Life Sciences Major Business
Table 135. APCER Life Sciences Pharmacovigilance Services Product and Services
Table 136. APCER Life Sciences Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. APCER Life Sciences Recent Developments/Updates
Table 138. APCER Life Sciences Competitive Strengths & Weaknesses
Table 139. Pharmya Basic Information, Manufacturing Base and Competitors
Table 140. Pharmya Major Business
Table 141. Pharmya Pharmacovigilance Services Product and Services
Table 142. Pharmya Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Pharmya Recent Developments/Updates
Table 144. Pharmya Competitive Strengths & Weaknesses
Table 145. A+Science Basic Information, Manufacturing Base and Competitors
Table 146. A+Science Major Business
Table 147. A+Science Pharmacovigilance Services Product and Services
Table 148. A+Science Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. A+Science Recent Developments/Updates
Table 150. A+Science Competitive Strengths & Weaknesses
Table 151. Midas Pharma Basic Information, Manufacturing Base and Competitors
Table 152. Midas Pharma Major Business
Table 153. Midas Pharma Pharmacovigilance Services Product and Services
Table 154. Midas Pharma Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Midas Pharma Recent Developments/Updates
Table 156. Midas Pharma Competitive Strengths & Weaknesses
Table 157. George Clinical Basic Information, Manufacturing Base and Competitors
Table 158. George Clinical Major Business
Table 159. George Clinical Pharmacovigilance Services Product and Services
Table 160. George Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. George Clinical Recent Developments/Updates
Table 162. George Clinical Competitive Strengths & Weaknesses
Table 163. Syneos Health Basic Information, Manufacturing Base and Competitors
Table 164. Syneos Health Major Business
Table 165. Syneos Health Pharmacovigilance Services Product and Services
Table 166. Syneos Health Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 167. Syneos Health Recent Developments/Updates
Table 168. Syneos Health Competitive Strengths & Weaknesses
Table 169. INPHARMATIS Basic Information, Manufacturing Base and Competitors
Table 170. INPHARMATIS Major Business
Table 171. INPHARMATIS Pharmacovigilance Services Product and Services
Table 172. INPHARMATIS Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 173. INPHARMATIS Recent Developments/Updates
Table 174. INPHARMATIS Competitive Strengths & Weaknesses
Table 175. Taimei Technology Basic Information, Manufacturing Base and Competitors
Table 176. Taimei Technology Major Business
Table 177. Taimei Technology Pharmacovigilance Services Product and Services
Table 178. Taimei Technology Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 179. Taimei Technology Recent Developments/Updates
Table 180. Taimei Technology Competitive Strengths & Weaknesses
Table 181. Extedo Basic Information, Manufacturing Base and Competitors
Table 182. Extedo Major Business
Table 183. Extedo Pharmacovigilance Services Product and Services
Table 184. Extedo Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 185. Extedo Recent Developments/Updates
Table 186. WCG Clinical Basic Information, Manufacturing Base and Competitors
Table 187. WCG Clinical Major Business
Table 188. WCG Clinical Pharmacovigilance Services Product and Services
Table 189. WCG Clinical Pharmacovigilance Services Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 190. Pharmacovigilance Services Raw Material
Table 191. Key Manufacturers of Pharmacovigilance Services Raw Materials
Table 192. Pharmacovigilance Services Typical Distributors
Table 193. Pharmacovigilance Services Typical Customers
List of Figure
Figure 1. Pharmacovigilance Services Picture
Figure 2. World Pharmacovigilance Services Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Pharmacovigilance Services Total Market Size (2017-2028) & (USD Million)
Figure 4. World Pharmacovigilance Services Market Size Market Share by Region (2017-2028)
Figure 5. United States Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 6. China Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 7. Europe Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 8. Japan Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 11. India Pharmacovigilance Services Market Size (2017-2028) & (USD Million)
Figure 12. Pharmacovigilance Services Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Pharmacovigilance Services by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Pharmacovigilance Services Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Pharmacovigilance Services Markets in 2021
Figure 17. United States VS China: Pharmacovigilance Services Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Pharmacovigilance Services Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Pharmacovigilance Services Market Size Market Share by Type in 2021
Figure 20. Adverse Event Case Management
Figure 21. Aggregate Reporting
Figure 22. Signal Intelligence
Figure 23. Risk Management
Figure 24. World Pharmacovigilance Services Market Size Market Share by Type (2017-2028)
Figure 25. World Pharmacovigilance Services Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Pharmacovigilance Services Market Size Market Share by Application in 2021
Figure 27. Biotechnology and Pharmaceuticals
Figure 28. Contract Research Organization
Figure 29. Hospital
Figure 30. KPO / BPO
Figure 31. Healthcare Institutions
Figure 32. Others
Figure 33. World Pharmacovigilance Services Market Size Market Share by Application (2017-2028)
Figure 34. Manufacturing Cost Structure Analysis of Pharmacovigilance Services in 2021
Figure 35. Manufacturing Process Analysis of Pharmacovigilance Services
Figure 36. Pharmacovigilance Services Industrial Chain
Figure 37. Distribution Channel Breakdown for Pharmacovigilance Services Shipments (%): 2017-2028
Figure 38. Direct Channel Pros & Cons
Figure 39. Indirect Channel Pros & Cons
Figure 40. Methodology
Figure 41. Research Process and Data Source
